#65: What's next in the Alphabet?
This week: How can Papa help with loneliness? What can investors and startups do to avoid another Theranos? Why are AI algorithms better at ruling out diseases than identifying them in people? Find out below. Pigeons unite.
News Bites 🥪
👴 Senior care platform Papa raises $150M to combat social isolation - The healthtech startup that matches older adults with trained “Papa Pals” to combat loneliness will use the investment to scale ‘the power of human connection’.
🛠 Clinical automation company secures Notable $100M to tackle the burden of healthcare admin - In healthcare where timing is everything, admin always manages to slow everything down. Notable is automating the administrative tasks faced by clinicians empowering them to practice at top of license and better serve patients.
🩸 How do we avoid another Theranos? Legal due diligence is the bread and butter of the investment process for startups. But what about medical diligence? Two industry veterans have launched MDisrupt, “the world’s first medical diligence company for the healthtech industry”, to try and prevent the next Theranos disaster.
💊 Isomorphic Labs is the latest addition to the Alphabet clan - Google’s parent company Alphabet takes a shot at the promising new field of AI drug discovery with their new company. Isomorphic Labs will build on research from DeepMind and will be headed up by DeepMind’s co-founder and chief executive, Demis Hassabis.
✅ AI gets a slap on the wrist for wrong diagnoses - This research study published in Informatics in Medicine Unlocked looks to tackle the ongoing challenge in healthcare AI of imbalanced datasets. By giving the algorithm a much bigger penalty for incorrectly telling a sick person that they are healthy, the algorithms performed significantly better with improved precision and recall.
What to Listen to 🔊
This week James is joined by Haribabu Arthanari based at Harvard Medical School and the Dana Farber Cancer Institute. With scientific training in the field of chemistry, physics and biophysics, his work focuses on better understanding the molecular architecture of micro-machines, proteins, and nucleic acids that orchestrate life…
What is neurotech? A far off sci-fi future? Or real technology making a difference today? These are some of the questions answered in this episode of Invent Health by TPP, the technology and product development company…
👂 Oto, a London-based digital health start-up that builds digital therapeutics for people with tinnitus, is looking for a talented Product Manager. This is an exciting opportunity to drive the product vision at a fast-growing startup. The early-stage startup is part of the Y Combinator W22 batch - you’ll be able to participate in one of the most prestigious start-up accelerators in the world along with the founders. Your work will have a lasting and real-world impact on people suffering from tinnitus around the world.
⏩ Global eCommerce giant Amazon enters the world of healthcare accelerators! The AWS Healthcare Accelerator delivered by PUBLIC helps startups use cloud technologies to develop solutions that tackle some of healthcare’s biggest issues. If you’re working in areas like elective care, population health, citizen access and workforce, check it out!
The GIANT Health Event 2021
Europe's largest & most valuable international festival of health-tech innovation is back!
Find inspiration and discover how technology is revolutionising healthcare with over 25 conferences, 450 speakers, immersive workshops, Beanstalks (a global startup competition for prizes) & more.
🗓 30 November - 1 December 📍 Business Design Center, London & online (hybrid)
🛒 Pigeon readers save 40% with our special promo code: somx40
➡️ Find out more & secure your tickets: https://www.giant.health/tickets